Investors / Sanara
Sanara
Venture capital
Sanara is a health-tech investment firm comprising Sanara Capital, a fund established in 2023, and Sanara Ventures, a seed-stage investment platform established in 2015 backed by Philips and Teva. It invests in and supports a portfolio of nearly 20 companies across both funds.
Invests inHealthcare & Biotech
In its own wordshealthtechdigital healthmedical devicesbio-convergenceisrael
Your fit with Sanara
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSanara lists 13 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 57% of its companies are based in Israel. It invests most often alongside Bold Capital Partners, Bridges Israel and BrightEdge.
No funding round on record names Sanara yet, so the figures come from its portfolio page.
Round figures show recent activity, not Sanara's whole history. Rounds on record name 0 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1292%
- No longer answers00%
- Points to another company18%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Bold Capital Partners
Compare Sanara head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| ActiveAging offers an AI-driven platform for health payers to optimize and manage benefits for their members | Healthcare & Biotech | Portfolio page | ||
| Discure develops and tests a minimally invasive, implantable device to treat degenerative disc disease and restore function to the spine | Healthcare & Biotech | Portfolio page | ||
| Luseed develops and introduces medical devices for treating brain aneurysms | Healthcare & Biotech | Portfolio page | ||
| Lydus Medical develops advanced solutions for microsurgery, providing automated delivery of standardized suturing threads to optimize anastomosis procedures. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| NovaSight develops eye tracking based vision care solutions for children. | Healthcare & Biotech | Portfolio page | ||
| The company optimizes and accelerates clinical trial outcomes by leveraging machine learning and predictive analysis. | Healthcare & Biotech | Portfolio page | ||
| Profility provides AI-powered post-acute care collaboration solutions | Healthcare & Biotech | Portfolio page | ||
| QLog provides a healthcare operations management platform for asset, workflow, and quality management | Healthcare & Biotech | Portfolio page | ||
| TailorMed provides an end-to-end solution that removes access, affordability, and adherence barriers across the medication journey, connecting patients to resources within the nation’s largest and most diverse network. | Healthcare & Biotech | Portfolio page | ||
| Ukko uses its advanced computational protein design platform to develop groundbreaking immuno-therapeutics for life-threatening allergies | Healthcare & Biotech | Portfolio page | ||
| Vflow21 develops vascular stents with a unique delivery system for brain endovascular treatments | Healthcare & Biotech | Portfolio page | ||
| Xtract Medical develops a novel engineering technology for lead extraction procedures | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- sanaracapital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Sanara's profile as data
Pull Sanara's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sanaracapital.com
# also
GET /v1/firms/sanaracapital.com/portfolio
GET /v1/firms/sanaracapital.com/coinvestors
GET /v1/firms/sanaracapital.com/news